FDA Law for Intellectual Property Lawyers
US Food and Drug Administration (FDA) regulatory considerations shape patent strategy, compliance, and risk management for products reviewed by the FDA. Topics include the interplay of patents and regulatory exclusivities, impact of FDA oversight on intellectual property safeguards, common challenges attorneys face in this sphere, and strategies for meeting regulatory compliance.
Speakers:
- Brian Malkin | Partner | Spencer Fane | Washington, DC
- Janet Linn | Counsel | Tarter Krinsky & Drogin LLP | New York, NY
Published Date:
- October 7, 2026
Format:
- Online On-Demand
Product Code:
- VRB61
Areas Of Professional Practice Credit(s):
- 2.0
Total Credit(s):
- 2.0

